LGL Partners’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
VCM
VPM
LGL Partners's LLY Position: Q1 2026 in Review
LGL Partners opened a new position in Eli Lilly (LLY) in Q1 2026: 1,293 shares worth $1.19M. The stake represents 0.49% of the portfolio and ranks #22 among its holdings. This is a return to the name: LGL Partners previously reported a position in LLY as recently as Q4 2024.
LGL Partners first reported a position in LLY in Q1 2019 and has held it in 25 quarters since. The position peaked at $1.8M in Q2 2024. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- LGL Partners held 1,293 shares of Eli Lilly worth $1.19M as of Q1 2026.
- Eli Lilly was a new LGL Partners position in Q1 2026.
- Eli Lilly made up 0.49% of LGL Partners's portfolio in Q1 2026, its #22 holding.
- LGL Partners first reported a position in Eli Lilly in Q1 2019 and has held it in 25 quarters since.
- LGL Partners's Eli Lilly position peaked at $1.8M in Q2 2024.
- 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on LGL Partners's 13F filing for Q1 2026, filed 14 May 2026.